The HUB Foundation for Organoid Technology announced today that it has signed a licensing agreement with STEMCELL Technologies Inc. for the manufacturing and worldwide distribution of cell culture media for growing Organoids. Organoids are mini-organs grown in tissue culture from small pieces of tissue derived from patients with cancer and other diseases, and represent an exciting new tool for scientific research and drug discovery and validation.
"We are pleased that STEMCELL will be our partner in making specialty media for growth of organoids available to the scientific community," says Prof. Hans Clevers, one of the founding directors of the HUB. "The broad availability of off-the-shelf cell culture media from a world leader in the development of specialized cell culture media and cell separation products represents an essential step in the further implementation of this exciting technology."
"We are delighted to bring these important culture media products quickly and reliably to researchers for the growth of tissue-specific organoids, and to be the exclusive commercial supplier," says Dr. Allen Eaves, CEO and President of STEMCELL Technologies. "The first product under this license will be released soon for culture of murine organoids, with products for human tissue to follow."
New study reveals lifestyle factors boosting IVF success